Consistent with the above remarked conclusions—based on the results of Yang et al.—NGR-based radiolabelled molecular agents are well-suited for the non-invasive characterisation of the receptor distribution of APN/CD13 positive tumours leaving out the invasive procedure of histological tissue sampling and related health ramifications [44,79,80]. The gene discussed is ANPEP; the disease is neoplasm.